98%
921
2 minutes
20
Introduction: Sarcopenia is a known risk factor for adverse outcomes after esophageal cancer (EC) surgery. Robot-assisted minimally invasive esophagectomy (RAMIE) offers numerous advantages, including reduced morbidity and mortality. However, no evidence exists to date comparing the development of sarcopenia after RAMIE and open esophagectomy (OE). The objective was to evaluate whether the development of sarcopenia within the first postoperative year after esophagectomy is associated with the surgical approach: RAMIE versus OE.
Methods: A total of 168 patients with EC were analyzed who either underwent total robotic or fully open Ivor Lewis esophagectomy in a propensity score-matched analysis. Sarcopenia was assessed using the skeletal muscle index (cm/m) and psoas muscle thickness per height (mm/m) on axial computed tomography scans during the first postoperative year; in total 540 computed tomography scans were evaluated.
Results: After 1-to-1 propensity score matching for confounders, 67 patients were allocated to RAMIE and OE groups, respectively. Skeletal muscle index in the OE group was significantly lower compared with the RAMIE group at the third (43.2 ± 7.6 cm/m versus 49.1 ± 6.9 cm/m, p = 0.001), sixth (42.7 ± 7.8 cm/m versus 51.5 ± 8.2 cm/m, p < 0.001) and ninth (43.0 ± 7.0 cm/m versus 49.9 ± 6.6 cm/m, p = 0.015) postoperative month. Similar results were recorded for psoas muscle thickness per height.
Conclusions: To our knowledge, this study is the first to suggest a substantial benefit of RAMIE compared with open esophagectomy in terms of postoperative sarcopenia. These results add further evidence to support the implementation of the robotic approach in multimodal therapy of EC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jtho.2022.10.018 | DOI Listing |
Surg Case Rep
September 2025
Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Kumamoto, Japan.
Introduction: Brain metastasis from gastric cancer is rare (0.5%) and often occurs with metastasis to other organs. We herein describe a very rare patient with a solitary brain metastasis from residual gastric cancer with no metastasis to other organs.
View Article and Find Full Text PDFBackground: Oesophageal squamous cell carcinoma is the predominant histopathological subtype of oesophageal cancer across the world, representing as many as 90% of all cases; however, within Western cohorts, it is a low-prevalence disease, and, as such, appropriately powered trials to establish a standard treatment paradigm in this population remain challenging. The aim of this study was to assess current practices and compare outcomes for patients with locally advanced oesophageal squamous cell carcinoma across the UK and Ireland.
Methods: This was a retrospective multicentre cohort study of patients managed with curative intent for squamous cell carcinoma of the middle or distal oesophagus in 23 hospitals across the UK and Ireland.
Aortoesophageal fistula (AEF) is a rare but life-threatening condition. Initial management typically includes thoracic endovascular aortic repair (TEVAR) or aortic graft replacement to achieve hemostasis, followed by esophagectomy with aortic graft replacement and greater omentum wrapping to eliminate the source of infection. We report a case of successful endoscopic closure of a chronic esophageal fistula secondary to AEF.
View Article and Find Full Text PDFIntroduction: Surgical resection, with or without neoadjuvant therapy, remains the primary treatment for oesophageal cancer. The two main surgical approaches are open oesophagectomy (OE) and hybrid minimally invasive oesophagectomy (HMIE). However, their relative safety and efficacy remain controversial.
View Article and Find Full Text PDFCureus
July 2025
Division of Digestive Diseases and Nutrition, Joy McCann Culverhouse Center for Swallowing Disorders, University of South Florida Morsani College of Medicine, Tampa, USA.
Achalasia is a disorder of unknown etiology that disrupts esophageal motility and esophagogastric junction outflow. Many long-term complications are associated with achalasia, including progression to megaesophagus and an increased risk for esophageal cancer. While current guidelines recommend against routine screening for cancer in patients with achalasia, many experts believe that routine endoscopic or radiographic screening at a yet-to-be-determined interval could provide essential data beyond evaluating for cancer.
View Article and Find Full Text PDF